Literature DB >> 1323131

Regulated high level expression of a human gamma-globin gene introduced into erythroid cells by an adeno-associated virus vector.

C E Walsh1, J M Liu, X Xiao, N S Young, A W Nienhuis, R J Samulski.   

Abstract

Gene therapy of severe hemoglobinopathies will require high-level expression of a transferred globin gene in erythroid cells. Distant regulatory elements flanking the beta-globin gene cluster, the locus control region, are needed for appropriate expression. We have explored the use of a human parvovirus, the adeno-associated virus (AAV), for globin gene transfer. The human A gamma-globin gene, linked to hypersensitivity site 2 from the locus control region of the beta-globin gene cluster, was subcloned into a plasmid (psub201) containing the AAV inverted terminal repeats. This construct was cotransfected with a helper plasmid containing trans-acting AAV genes into human 293 cells that had been infected with adenovirus. The recombinant AAV vector containing hypersensitivity site 2 stably introduced on average one or two unrearranged proviral copies into human K562 erythroleukemia cells. The transferred globin gene exhibited normal regulation upon hemin induction of erythroid maturation and was expressed at a level equivalent to a native chromosomal A gamma-globin gene.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1323131      PMCID: PMC49685          DOI: 10.1073/pnas.89.15.7257

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  36 in total

1.  ADENOVIRUS-ASSOCIATED DEFECTIVE VIRUS PARTICLES.

Authors:  R W ATCHISON; B C CASTO; W M HAMMON
Journal:  Science       Date:  1965-08-13       Impact factor: 47.728

Review 2.  Use of adeno-associated virus as a general transduction vector for mammalian cells.

Authors:  N Muzyczka
Journal:  Curr Top Microbiol Immunol       Date:  1992       Impact factor: 4.291

3.  Tandem AP-1-binding sites within the human beta-globin dominant control region function as an inducible enhancer in erythroid cells.

Authors:  P A Ney; B P Sorrentino; K T McDonagh; A W Nienhuis
Journal:  Genes Dev       Date:  1990-06       Impact factor: 11.361

4.  Mechanism of DNase I hypersensitive site formation within the human globin locus control region.

Authors:  C H Lowrey; D M Bodine; A W Nienhuis
Journal:  Proc Natl Acad Sci U S A       Date:  1992-02-01       Impact factor: 11.205

5.  K562 human leukaemic cells synthesise embryonic haemoglobin in response to haemin.

Authors:  T R Rutherford; J B Clegg; D J Weatherall
Journal:  Nature       Date:  1979-07-12       Impact factor: 49.962

Review 6.  Retrovirus packaging cells.

Authors:  A D Miller
Journal:  Hum Gene Ther       Date:  1990       Impact factor: 5.695

7.  Hematologic responses of patients with sickle cell disease to treatment with hydroxyurea.

Authors:  G P Rodgers; G J Dover; C T Noguchi; A N Schechter; A W Nienhuis
Journal:  N Engl J Med       Date:  1990-04-12       Impact factor: 91.245

8.  Site-specific integration by adeno-associated virus.

Authors:  R M Kotin; M Siniscalco; R J Samulski; X D Zhu; L Hunter; C A Laughlin; S McLaughlin; N Muzyczka; M Rocchi; K I Berns
Journal:  Proc Natl Acad Sci U S A       Date:  1990-03       Impact factor: 11.205

9.  Hypersensitive site 4 of the human beta globin locus control region.

Authors:  S Pruzina; O Hanscombe; D Whyatt; F Grosveld; S Philipsen
Journal:  Nucleic Acids Res       Date:  1991-04-11       Impact factor: 16.971

10.  Targeted integration of adeno-associated virus (AAV) into human chromosome 19.

Authors:  R J Samulski; X Zhu; X Xiao; J D Brook; D E Housman; N Epstein; L A Hunter
Journal:  EMBO J       Date:  1991-12       Impact factor: 11.598

View more
  44 in total

Review 1.  Adeno-associated virus vectors and hematology.

Authors:  D W Russell; M A Kay
Journal:  Blood       Date:  1999-08-01       Impact factor: 22.113

Review 2.  Gene transfer approaches to the lysosomal storage disorders.

Authors:  J A Barranger; E O Rice; W P Swaney
Journal:  Neurochem Res       Date:  1999-04       Impact factor: 3.996

3.  Genetic fate of recombinant adeno-associated virus vector genomes in muscle.

Authors:  Bruce C Schnepp; K Reed Clark; Dori L Klemanski; Christina A Pacak; Philip R Johnson
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

4.  Adeno-associated virus vector integration junctions.

Authors:  E A Rutledge; D W Russell
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

5.  Novel adeno-associated virus vector vaccine restricts replication of simian immunodeficiency virus in macaques.

Authors:  Philip R Johnson; Bruce C Schnepp; Mary J Connell; Daniela Rohne; Suzanne Robinson; Georgia R Krivulka; Carol I Lord; Rebekah Zinn; David C Montefiori; Norman L Letvin; K Reed Clark
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

6.  Prolongation of heart allograft survival after long-term expression of soluble MHC class I antigens and vIL-10 in the liver by AAV-plasmid-mediated gene transfer.

Authors:  A Doenecke; E Frank; M N Scherer; H-J Schlitt; E K Geissler
Journal:  Langenbecks Arch Surg       Date:  2008-03-06       Impact factor: 3.445

7.  Recombinant adeno-associated virus mediates a high level of gene transfer but less efficient integration in the K562 human hematopoietic cell line.

Authors:  P Malik; S A McQuiston; X J Yu; K A Pepper; W J Krall; G M Podsakoff; G J Kurtzman; D B Kohn
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

8.  Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector.

Authors:  X Xiao; J Li; R J Samulski
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

Review 9.  Prospects for gene therapy in sports medicine.

Authors:  T G Gerich; F H Fu; P D Robbins; C H Evans
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  1996       Impact factor: 4.342

10.  A p5 integration efficiency element mediates Rep-dependent integration into AAVS1 at chromosome 19.

Authors:  Nicola J Philpott; Janette Gomos; Kenneth I Berns; Erik Falck-Pedersen
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-09       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.